Analyst Price Target is $2.75
▲ +428.44% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Sintx Technologies in the last 3 months. The average price target is $2.75, with a high forecast of $2.75 and a low forecast of $2.75. The average price target represents a 428.44% upside from the last price of $0.52.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Sintx Technologies. This Buy consensus rating has held steady for over two years.
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.